Pebbles Fagan1, Pallav Pokhrel2, Thaddeus A Herzog2, Ian S Pagano2, Adrian A Franke2, Mark S Clanton3, Linda A Alexander4, Dennis R Trinidad5, Kari-Lyn K Sakuma6, Carl A Johnson5, Eric T Moolchan7. 1. Cancer Prevention and Control Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI; pfagan@cc.hawaii.edu. 2. Cancer Prevention and Control Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI; 3. TMF Health Quality Institute, Austin, TX; 4. College of Public Health, University of Kentucky, Lexington, KY; 5. School of Community and Global Health, Claremont Graduate University, Claremont, CA; 6. College of Public Health and Human Sciences, Oregon State University, Corvallis, OR; 7. Cambridge, MA.
Abstract
INTRODUCTION: Menthol cigarette smoking may increase the risk for tobacco smoke exposure and inhibit nicotine metabolism in the liver. Nicotine metabolism is primarily mediated by the enzyme CYP2A6 and the nicotine metabolite ratio (NMR = trans 3' hydroxycotinine/cotinine) is a phenotypic proxy for CYP2A6 activity. No studies have examined differences in this biomarker among young adult daily menthol and nonmenthol smokers. This study compares biomarkers of tobacco smoke exposure among young adult daily menthol and nonmenthol smokers. METHODS: Saliva cotinine and carbon monoxide were measured in a multiethnic sample of daily smokers aged 18-35 (n = 186). Nicotine, cotinine, the cotinine/cigarette per day ratio, trans 3' hydroxycotinine, the NMR, and expired carbon monoxide were compared. RESULTS: The geometric means for nicotine, cotinine, and the cotinine/cigarette per day ratio did not significantly differ between menthol and nonmenthol smokers. The NMR was significantly lower among menthol compared with nonmenthol smokers after adjusting for race/ethnicity, gender, body mass index, and cigarette smoked per day (0.19 vs. 0.24, P = .03). White menthol smokers had significantly higher cotinine/cigarettes per day ratio than white nonmenthol smokers in the adjusted model. White menthol smokers had a lower NMR in the unadjusted model (0.24 vs. 0.31, P = .05) and the differences remained marginally significant in the adjusted model (0.28 vs. 0.34, P = .06). We did not observe these differences in Native Hawaiians and Filipinos. CONCLUSIONS: Young adult daily menthol smokers have slower rates of nicotine metabolism than nonmenthol smokers. Studies are needed to determine the utility of this biomarker for smoking cessation treatment assignments.
INTRODUCTION:Menthol cigarette smoking may increase the risk for tobacco smoke exposure and inhibit nicotine metabolism in the liver. Nicotine metabolism is primarily mediated by the enzyme CYP2A6 and the nicotine metabolite ratio (NMR = trans 3' hydroxycotinine/cotinine) is a phenotypic proxy for CYP2A6 activity. No studies have examined differences in this biomarker among young adult daily menthol and nonmenthol smokers. This study compares biomarkers of tobacco smoke exposure among young adult daily menthol and nonmenthol smokers. METHODS: Saliva cotinine and carbon monoxide were measured in a multiethnic sample of daily smokers aged 18-35 (n = 186). Nicotine, cotinine, the cotinine/cigarette per day ratio, trans 3' hydroxycotinine, the NMR, and expired carbon monoxide were compared. RESULTS: The geometric means for nicotine, cotinine, and the cotinine/cigarette per day ratio did not significantly differ between menthol and nonmenthol smokers. The NMR was significantly lower among menthol compared with nonmenthol smokers after adjusting for race/ethnicity, gender, body mass index, and cigarette smoked per day (0.19 vs. 0.24, P = .03). White menthol smokers had significantly higher cotinine/cigarettes per day ratio than white nonmenthol smokers in the adjusted model. White menthol smokers had a lower NMR in the unadjusted model (0.24 vs. 0.31, P = .05) and the differences remained marginally significant in the adjusted model (0.28 vs. 0.34, P = .06). We did not observe these differences in Native Hawaiians and Filipinos. CONCLUSIONS: Young adult daily menthol smokers have slower rates of nicotine metabolism than nonmenthol smokers. Studies are needed to determine the utility of this biomarker for smoking cessation treatment assignments.
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Christopher Havel; Margaret Wilson; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-10-20 Impact factor: 4.254
Authors: Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox Journal: Addict Behav Date: 2012-11-29 Impact factor: 3.913
Authors: Sam N Cwalina; Anuja Majmundar; Jennifer B Unger; Jessica L Barrington-Trimis; Mary Ann Pentz Journal: Drug Alcohol Depend Date: 2019-11-15 Impact factor: 4.492
Authors: Suchitra Krishnan-Sarin; Barry G Green; Grace Kong; Dana A Cavallo; Peter Jatlow; Ralitza Gueorguieva; Eugenia Buta; Stephanie S O'Malley Journal: Drug Alcohol Depend Date: 2017-08-31 Impact factor: 4.492
Authors: Nancy C Jao; Anna K Veluz-Wilkins; Matthew J Smith; Allison J Carroll; Sonja Blazekovic; Frank T Leone; Rachel F Tyndale; Robert A Schnoll; Brian Hitsman Journal: Exp Clin Psychopharmacol Date: 2017-06 Impact factor: 3.157
Authors: Gerald W Valentine; Elise E DeVito; Peter I Jatlow; Ralitza Gueorguieva; Mehmet Sofuoglu Journal: J Psychopharmacol Date: 2018-05-23 Impact factor: 4.153
Authors: Christie D Fowler; Cassandra D Gipson; Bethea A Kleykamp; Laura E Rupprecht; Paul T Harrell; Vaughan W Rees; Thomas J Gould; Jason Oliver; Deniz Bagdas; M Imad Damaj; Heath D Schmidt; Alexander Duncan; Mariella De Biasi Journal: Nicotine Tob Res Date: 2018-06-07 Impact factor: 4.244